$158,000 ALS drug pulled from market after failing in large clinical trial
Ars Technica 2024-04-05
Summary:
The drug is now unavailable to new patients; its maker to lay off 70% of employees.
Link:
https://arstechnica.com/?p=2015321From feeds:
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific MethodCyberlaw » Ars Technica
Music and Digital Media » Ars Technica